论文部分内容阅读
2005年8月19日,美国德克萨斯州一个陪审团就备受全世界关注的全美首起“万络人身伤害诉讼案”做出裁决,判决世界医药巨头默克公司(在中国称“默沙东”)支付该国的一名寡妇2.53亿美元的赔偿金,这名寡妇卡洛尔·恩斯特女士的丈夫罗伯特·恩斯特因服用“万络”死亡。到目前为止,全球已有6万名患者因服用“万络”造成死亡,美国已有4200多起涉及“万络”致死的诉讼案,默克公司还在加拿大、巴西、澳大利亚、以色列等国家和地区在有关“万络”的诉讼中成为被告。据有关专家统计,中国曾有约200万患者服用过“万络”,但是目前还没有一例“万络”不良反应病例上报到国家药品不良反应监测中心。为何国外不断出现“万络”诉讼案,而用药量如此之大的中国却平静如水?难道中国服用“万络”的200万患者中居然没有一起不良反应病例?本刊记者就此进行了采访,同时本刊从即日起开通了热线投诉电话(010)66184891。凡曾经因服用“万络”而出现过心脏病发作、心肌梗塞和心脏猝死等各种心血管系统不良反应、甚至是怀疑家人因长期服用该药而死亡者,均可与本刊联系,本刊将以最快的速度上报给北京市药品不良反应监测中心,最大限度地维护患者的合法权益和生命健康安全。
On August 19, 2005, a jury in Texas, United States, ruled on the nationwide first case of the “Wanhuo Personal Injury Lawsuit” that has drawn the world’s attention. It ruled that the world pharmaceutical giant Merck (in China said “ Merck East ”) paid a $ 253 million indemnity for a widow in the country, and Robert Ernst, the husband of the widow Ms. Carroll Ernst, died of“ Wanolu ”. So far, 60,000 patients worldwide have died as a result of taking “Wanluo”. There are over 4,200 U.S. cases involving the death of “Wanluo” and Merck is still in Canada, Brazil, Australia, Israel and other countries And the district became defendants in the lawsuit concerning “Wanluo”. According to the experts’ statistics, there were about 2 million patients who used “Wanluo” in China. However, no case of “Wanluo” adverse reaction has been reported to the National Adverse Drug Reaction Monitoring Center. Why do foreign countries keep appearing “Wanluo” lawsuit, while the amount of such large doses of Chinese medicine is calm? Does China take “Wanluo” of 200 million patients with no adverse reactions in the case? Correspondents interviewed in this regard, At the same time from the publication of our hotline complaints hotline (010) 66184891. Anyone who has suffered a heart attack, myocardial infarction and sudden cardiac death due to taking “Wanluo” and other cardiovascular system adverse reactions, and even suspected family members died of long-term use of the drug can be contacted with this The journal will be reported to the Beijing Municipal Center for Drug Adverse Reaction Monitoring as soon as possible, to maximize the patient’s legitimate rights and interests and life, health and safety.